In 2025, the Rx IP Update team at Smart & Biggar reported on a number of developments in Canadian life sciences IP and regulatory law. Highlights from 2025 are below. 1. PM(NOC) Regulations update; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results